Compound Summary
Compound Information
化合物待补充
药名: | Quisqualic acid |
别名: | CTK4J6551; C08296; 2-amino-3-(3,5-dioxo[1,2,4]oxadiazolidin-2-yl)propionic acid; LS-175398; ACM52809071; ASNFTDCKZKHJSW-REOHCLBHSA-N; NCGC00024489-01; 1,2,4-Oxadiazolidine-2-propanoicacid, a-amino-3,5-dioxo-, (aS)-; 3-(3,5-Dioxo-1,2,4-oxadiazolidin-2-yl)-L-alanine; (2S)-2-amino-3-(3,5-diketo-1,2,4-oxadiazolidin-2-yl)propionic acid; HMS3263O19; AK668624; [3H]quisqualate; 8OC22C1B99; NCGC00024489-03; 1p1o; C5H7N3O5; SCHEMBL136819; V0329; SR-01000075471-1; 52284-24-9; (+)-Quisqualic acid; Tox21_501039; GTPL1372; AKOS024456826; SR-01000597681-1; Q2128_SIGMA; (2S)-2-amino-3-(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)propanoic acid; QUISQUALIC ACID; 809Q071; SR-01000075471-5; SR-01000597681; (S)-2-amino-3-(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)propanoic acid; EU-0101039; AC1Q6GK0; 1,2,4-Oxadiazolidine-2-propanoic acid, alpha-amino-3,5-dioxo-, (S)-; NCGC00024489-04; KB-60323; CHEMBL279956; L(+)-alpha-Amino-3,5-dioxo-1,2,4-oxadiazolidine-2-propanoic acid; ST50825297; AC1ODZB5; L-Quisqualic acid; FCH4012693; Quisqualic acid, powder; 2jbk; BDBM50164445; SCHEMBL13319908; PDSP1_000814; MLS001074741; Q 2128; CCG-205116; PDSP2_000801; quisqualicacid; DB02999; D06DUE; 1mm6; D0W6JO; LP01039; NCGC00024489-05; HMS2233G05; (2S)-2-amino-3-(3,5-dioxo(1,2,4-oxadiazolidin-2-yl))propanoic acid; Lopac0_001039; ZINC897456; CHEMBL168279; beta-(3,5-Dioxo-1,2,4-oxadiazolidin-2-yl)-L-alanine; QC-11635; 2or4; GTPL1370; 2-Amino-3-(3,5-dioxo-[1,2,4]oxadiazolidin-2-yl)-propionic acid(Quisqualic acid); MFCD00069337; 52809-07-1; Quisqualate, L; NCGC00024489-02; QUS; ()-Quisqualic Acid; AC1L23YS; UNII-8OC22C1B99; 51821-59-1; SMR000471890; BDBM17660; C-52964; Quisqualate; (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID; MolPort-003-939-212; (L)-(+)-?-Amino-3,5-dioxo-1,2,4-oxadiazolidine-2-propanoic acid; Quisqualic acid; Tocris-0188; CHEBI:8734; BN0434; SR-01000075471; 1mm7; NCGC00261724-01; FT-0604435 |
成分: | HBIN041792 |
OB_score: | 4.36741 |
CAS_id: | 52809-07-1 |
SymMap_id: | SMIT00309;SMIT02549 |
TCMID_id: | 23176;18437 |
TCMSP_id: | MOL010892 |
PubChem_id: | 40539 |
化合物对应的植物
| 植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
|---|
| TCMBANKHE006031 | Bulbus Fritillariae Ussuriensis | 平贝母 | To remove heat from the lung, relieve cough and resolve phlegm./Dry cough due to lung dryness, dry cough, yin vacuity taxation cough, cough with phlegm and blood. | |||
| TCMBANKHE007295 | Radix Aucklandiae | 木香 | To relieve pain by promoting the flow of qi, and to improve digestion by reinforcing the spleen function. /Distending pain in chest and stomach duct, diarrhea and tenesmus, non-digestion of food accumu lation, no thought of food and drink. | |||
| TCMBANKHE004393/YEM-220 | Quisqualis indica|Quisqualis indica L. | 使君子叶|使君子 | 使君子 | 云南民族药物志：第二卷 | To rectify qi and fortify spleen, resolve toxin and kill worms./Child gan accumulation, distention fullness in stomach duct and abdomen, worm accumulation, ulcerating sore and boil. | 阿昌族/傣族/德昂族/景颇族/傈僳族/普米族/佤族/瑶族 |
| TCMBANKHE003599/YEM-220 | Quisqualis indica L. | 使君子根|使君子 | 使君子 | 云南民族药物志：第二卷 | 阿昌族/傣族/德昂族/景颇族/傈僳族/普米族/佤族/瑶族 | |
| TCMBANKHE004087/YEM-220 | Fructus Quisqualis|Quisqualis indica L. | 使君子 | 使君子 | 云南民族药物志：第二卷 | To kill worms./Ascariasis, oxyuria disease, child gan accumulation. | 阿昌族/傣族/德昂族/景颇族/傈僳族/普米族/佤族/瑶族 |
| TCMBANKHE004716/YEM-220 | Quisqualis indica var. villosa|Quisqualis indica L. | 毛使君子|使君子 | 使君子 | 云南民族药物志：第二卷 | 阿昌族/傣族/德昂族/景颇族/傈僳族/普米族/佤族/瑶族 |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
化合物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE006909 | GRM1 | GPRC1A; MGLU1; MGLUR1; PPP1R85; SCA44; SCAR13 | glutamate metabotropic receptor 1 |
滇ICP备16009434号-1 |
Dai SX Lab